期刊文献+

富马酸丙酚替诺福韦合成工艺改进 被引量:2

Progress Improvement of The Synthesis of Tenofovir Alafenamide Fumarate
下载PDF
导出
摘要 对富马酸丙酚替诺福韦的合成工艺进行了改进,以干燥的替诺福韦为起始原料,与亚磷酸三苯酯反应得到(R)-9-(2-(苯基磷酰基甲氧基)丙基)腺嘌呤(3);3被氯化亚砜氯代得(R)-9-(2-(((苯基)(氯代)(磷酰基)甲氧基)丙基)腺嘌呤(4);4与L-丙氨酸异丙酯盐酸盐缩合得9-((R)-2-(((S)-((1-(异丙氧基羰基)乙基)氨基)苯氧基磷酰基)甲氧基)丙基)腺嘌呤(5);5经析晶纯化得9-((R)-2-(((S)-(((S)-1-(异丙氧基羰基)乙基)氨基)苯氧基磷酰基)甲氧基)丙基)腺嘌呤(丙酚替诺福韦,6);6与富马酸成盐得富马酸丙酚替诺福韦,其结构经1H NMR,13C NMR, MS(ESI),元素分析和XRD确证。按改进工艺进行公斤级规模放大,产品总收率达到32.2%,化学纯度99.92%,非对映异构体纯度99.99%。 The synthesis progress of tenofovir alafenamide fumarate has been developed. This route involves the dry tenofovir(2) as a starting material, which reaction with triphenyl phosphite to obtain(R)-9-[2-(phenylphosphonomethoxy)propyl]adenine(3). 3 is treated with thionyl chloride to achieve(R)-9-(2-(((phenyl)(chloro)phosphoryl) methoxy)-propyl) adenine(4), which is converted to 9-((R)-2-(((S)-((1-(isopropoxycarbonyl)ethyl)amino)phenoxyphosphoryl)methoxy)propyl) adenine(5) by condensation with L-alanine isopropyl ester hydrochloride. After purification, tenofovir alafenamide(6) is obtained. Finally, tenofovir alafenamide fumarate is obtained by the reaction of 6 with fumaric acid. The structure has been confirmed by 1H NMR, 13C NMR, MS(ESI), elemental analysis and XRD. Kilogram-scale production has been achieved according to the improved process with a total yield of 32.2%, chemical purity of 99.92% and diastereomer purity of 99.99%.
作者 赵明礼 王喆 舒伟 柴雨柱 徐丹 朱春霞 ZHAO Ming-li;WANG Zhe;SHU Wei;CHAI Yu-zhu;XU Dan;ZHU Chun-xia(Nanjing Chia Tai-Tianqing Pharmaceutical Co.,Ltd.,Nanjing 210046,China)
出处 《合成化学》 CAS 北大核心 2020年第3期222-228,共7页 Chinese Journal of Synthetic Chemistry
基金 江苏省高层次创新创业人才引进计划。
关键词 富马酸丙酚替诺福韦 抗乙肝病毒 药物合成 工艺改进 放大 tenofovir alafenamide fumarate anti-hepatitis B virus drug synthesis process improvement scale-up experiment
  • 相关文献

参考文献10

二级参考文献38

  • 1周婷,谢蓝.HIV非核苷类逆转录酶抑制剂研究进展[J].药学学报,2004,38(8):666-672. 被引量:17
  • 2Shaw JP, Sueoka CM, Oliyai R, et al. Metabohsm and pharma- cokinetics of novel oral prodrugs of 9-[ (R) -2-( phosphonome- thoxy) propyl ] adenine (PMPA) in dogs [ J]. Pharm Res, 1997, 14(12) : 1824-1829.
  • 3Robbins BL, Srinivas RV, Kim C, et al. Anti-human immunode- ficiency virus activity and cellular metabolism of a potential pro- drug of the acyclic nucleoside phosphonate 9-R- (2-phosphono- methoxypropyl ) adenine(PMPA), bis ( isopropyloxymethylcarbonyl ) PMPA[ J ]. Antimicrob Agents Chemother, 1998, 42 (3) :612-617.
  • 4Lyseng-Williamson KA, Reynolds NA, Plosker GL. Tenofovir disoproxil fumarate : Tenofov!r disoproxil fumarate : a review of its use in the management of HIV infection [ J ]. Drugs, 2005, 65 (3) :413-432.
  • 5Declercq E. Discovery and development of tenofovir disoproxil fumarate [ M ]//Kazmierski WM, ed. Antiviral Drugs : From Bas- ic Discovel3' through Clinical Trials. Hoboken, N J, USA : John Wiley & Sons. Ltd, 2011 : 85-101.
  • 6Delaney WE 4th, Ray AS, Yang H, et al. Intracellular metabo- lism and in vitro activity of tenofovir against hepatitis B virus [ J ]. Antimicrob Agents Chemother, 2006, 50(7 ) :2471-2477.
  • 7Tchernev K, Buggisch P, Weilert F, et al. Three-year efficacy and safety of tenofovir disop-roxil fumarate treatment for chronic hepatitis B[J]. Gastroenterology, 2011, 140(1) :132-143.
  • 8Snow-Lampart A, Chappell B, Curtis M, et al. No resistance to tenofovir disoproxil fumarate detected after up to 144 weeks of therapy in patients monoinfected with chronic hepatitis B virus [J]. Hepatology, 2011, 53(3) :763-773.
  • 9Tang YB, Peng ZG, Liu ZY, et al. Some new aeyelic nueleotide analogues as antiviral prodrugs : synthesis and bioactivities in vitro [J]. Bioorg Med Chem Lett, 2007, 17(22) :6350-6353.
  • 10Painter GR, Almond MR, Trost LC, et al. Evaluation of hexade- cyloxyprupyl-9-R-[ 2-( phosph onomethoxy ) propyl ]-adenine, CMX157, as a potential treatment for human immunodeficiency virus type 1 and hepatitis B virus infections [ J ]. Antimicrob Agents Chemother, 2007, 51 (10) :3505-3509.

共引文献47

同被引文献12

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部